PHAR vs GILD: Which Stock is Better?
Side-by-side comparison of Pharming Group Nv and Gilead Sciences Inc in 2026
PHAR
Pharming Group Nv
$17.35
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | PHAR | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.22B | $171.97B | GILD |
| P/E Ratio | 433.25 | 20.44 | GILD |
| EPS (TTM) | $0.04 | $6.78 | GILD |
| Revenue Growth | 0.1% | 0.0% | PHAR |
| Gross Margin | 87.9% | 78.8% | PHAR |
Analyze PHAR
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or GILD a better investment?
Comparing PHAR and GILD: Pharming Group Nv has a market cap of $1.22B while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and GILD?
PHAR (Pharming Group Nv) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or GILD?
Based on P/E ratios, GILD trades at a lower multiple (20.4x vs 433.3x).
Which is growing faster: PHAR or GILD?
PHAR has higher revenue growth at 0.1% vs 0.0% for GILD.
Which company is more profitable: PHAR or GILD?
Pharming Group Nv (PHAR) has higher gross margins at 87.9% compared to 78.8% for GILD.
Which is the larger company: PHAR or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $1.22B for PHAR.
Should I buy PHAR or GILD in 2026?
Both PHAR and GILD have investment merit. PHAR trades at $17.35 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and GILD stock?
Key differences: Market Cap ($1.22B vs $171.97B), P/E Ratio (433.3x vs 20.4x), Revenue Growth (0.1% vs 0.0%), Gross Margin (87.9% vs 78.8%).